Fennec Pharmaceuticals FENC
NASDAQ FENC
$10.46 +0.19 (+1.85%)
At close: Oct 20, 2026 · 4:00 PM EDT

Fennec Pharmaceuticals (FENC) Operating Leases (2023)

Updated

Fennec Pharmaceuticals' Operating Leases came in at $2,000 for Q4 2023, down 71.4% from the prior quarter.

Analysis

Fennec Pharmaceuticals (FENC) Operating Leases (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Fennec Pharmaceuticals 361.69 Mn 243.00 Mn 17.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2,000.00
Sep 30, 2023 7,000.00
API Access

Fennec Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=FENC&period=max&api_key=YOUR_API_KEY